Open Innovation at $25 Billion AstraZeneca

az-feat

Scott Wilkins of AstraZeneca and his colleague Rob Albert discuss the roots of the open innovation program at AstraZeneca and more.

Register For Access

You must be signed in as a member or registered user to view this article.

Register For 5 Free Articles!

Not quite ready to become a member? Register for free to have a look at this article and more:

  • Case studies & best practices advice from your peers
  • Webcasts, videos, and conference calls
  • Downloadable tools, templates, and strategy documents
  • Excerpts from our quarterly research reports
  • …and other useful resources you won’t find anywhere else.

 

If you are already a registered user or a member you can SIGN IN now